Can infections cause a false rise in N-terminal pro b-type natriuretic peptide (NT-proBNP) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Infections Can Cause False Elevation in NT-proBNP Levels

Yes, infections can cause a false rise in NT-proBNP levels, even in the absence of heart failure or cardiac dysfunction. This is a clinically significant consideration when interpreting NT-proBNP results in patients with suspected heart failure who also have concurrent infections.

Mechanism and Evidence

  • Systemic infections and inflammatory states can directly increase NT-proBNP levels through several mechanisms:

    • Inflammatory cytokines may stimulate BNP production
    • Endotoxins from bacterial infections can trigger NT-proBNP release
    • Sepsis-induced hemodynamic changes can cause cardiac stress 1
  • In a controlled study, even healthy individuals with normal cardiac function showed significant increases in NT-proBNP levels after administration of E. coli endotoxin, demonstrating that infection/inflammation alone can elevate NT-proBNP 1

  • The elevation correlates with inflammatory markers like C-reactive protein (CRP) and body temperature, not just with cardiac parameters 1

Magnitude of Elevation

  • In patients with infectious diseases, NT-proBNP levels can be significantly elevated (median: 193 pg/mL) compared to baseline, though typically not as high as in primary cardiac disease (median: 548 pg/mL) 2

  • In community-acquired infections, NT-proBNP levels can reach an average of 5897 pg/mL compared to 108 pg/mL in healthy controls 3

  • Lower respiratory tract infections tend to cause the highest elevations in NT-proBNP compared to other infection sites 3

Clinical Implications

  • When interpreting NT-proBNP in patients with suspected heart failure:

    • Rule-out cutoffs remain reliable (<100 pg/mL for BNP, <300 pg/mL for NT-proBNP) even in the presence of infection 4
    • Rule-in cutoffs (>400 pg/mL for BNP) should be interpreted with caution in patients with active infections 4, 5
  • In septic patients, NT-proBNP shows a biphasic pattern:

    • Initial elevation in all septic patients regardless of cardiac function
    • Persistent elevation on day 2 and beyond suggests actual cardiac dysfunction 6

Other Non-Cardiac Causes of NT-proBNP Elevation

Beyond infections, other conditions that can falsely elevate NT-proBNP include:

  • Renal dysfunction (impairs clearance)
  • Advanced age
  • Atrial fibrillation
  • Pulmonary embolism
  • Pulmonary hypertension
  • Sepsis
  • Critical illness 4, 5

Practical Approach to Interpretation

  1. Consider pre-test probability of heart failure vs. infection

  2. Use lower thresholds for excluding heart failure (<100 pg/mL for BNP, <300 pg/mL for NT-proBNP)

  3. In patients with values in the "gray zone" (100-400 pg/mL for BNP):

    • Look for clinical evidence of infection (fever, elevated WBC, CRP)
    • Consider echocardiography to directly assess cardiac function
    • Serial measurements may help differentiate - persistent elevation beyond 48-72 hours after treating infection suggests cardiac etiology 6
  4. In critically ill patients with both suspected heart failure and infection:

    • Use NT-proBNP as part of a comprehensive assessment
    • Higher values correlate with worse outcomes regardless of cause 3
    • Consider age-adjusted cutoffs for NT-proBNP (450 pg/mL for <50 years, 900 pg/mL for 50-75 years, 1800 pg/mL for >75 years) 4

Remember that NT-proBNP elevation in infection is not truly "false" but reflects actual cardiac stress, even if transient and not indicative of chronic heart failure.

References

Research

Plasma NT-proBNP increases in response to LPS administration in healthy men.

Journal of applied physiology (Bethesda, Md. : 1985), 2008

Research

Brain natriuretic peptide plasma levels as a marker of prognosis in patients with community-acquired infection.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Heart Failure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.